Financials Pharma Equity Group A/S

Equities

PEG A

DK0061155009

Investment Holding Companies

Market Closed - Nasdaq Copenhagen 08:19:12 13/05/2024 pm IST 5-day change 1st Jan Change
0.1945 DKK +2.91% Intraday chart for Pharma Equity Group A/S -18.96% -54.77%

Valuation

Fiscal Period: December 2023
Capitalization 1 439.9
Enterprise Value (EV) 1 465.9
P/E ratio -18.9 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -18.6 x
EV / FCF -71,69,903 x
FCF Yield -0%
Price to Book 11.3 x
Nbr of stocks (in thousands) 10,22,964
Reference price 2 0.4300
Announcement Date 20/03/24
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales - -
EBITDA 1 -11.02 -25.01
EBIT 1 -11.28 -25.29
Operating Margin - -
Earnings before Tax (EBT) 1 -11.3 -26.84
Net income 1 -9.444 -24.61
Net margin - -
EPS 2 -0.0100 -0.0228
Free Cash Flow - -64.98
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 20/03/24 20/03/24
1DKK in Million2DKK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 - 26
Net Cash position 1 2.25 -
Leverage (Debt/EBITDA) - -1.039 x
Free Cash Flow - -65
ROE (net income / shareholders' equity) - -85.1%
ROA (Net income/ Total Assets) - -30.7%
Assets 1 - 80.05
Book Value Per Share 2 0.0200 0.0400
Cash Flow per Share 2 0 0
Capex - 0.07
Capex / Sales - -
Announcement Date 20/03/24 20/03/24
1DKK in Million2DKK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. PEG A Stock
  4. Financials Pharma Equity Group A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW